Aravindkumar Sundaram

Aravindkumar Sundaram

Auto-generated profile, based on publicly available information

Aravindkumar Sundaram

Department of Biomedical Sciences and BioMedical Sciences Graduate Program (BMSGP) Chonnam National University Medical School Gwangju 61469 Republic of Korea

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2020 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
ASAravindkumar Sundaram
Aravindkumar Sundaram
JPJoice Sophia Ponraj
Joice Sophia Ponraj
CWCong Wang
Cong Wang
WPWeng Kung Peng
Weng Kung Peng
RMRajesh Kumar Manavalan
Rajesh Kumar Manavalan
JGJoao Gaspar
Joao Gaspar
The 2D layered structured material with unique surface terminations and properties have showed great potential in variety of biomedical research fields including drug delivery and cancer therapeutics which forms the major focus of this review. MXenes as a multifunctional two-dimensional (2D) nanomaterial, has also received momentous research interest in oncology resulting from its intriguing structure and fascinating properties of magnetism and photodynamic properties such as luminescent, conductivity, magnetism, non-toxicity and its bio compatibility. This reported review intends to cover exclusively the synthesis and utilization of MXenes in oncological applications, and subsequently its future outlook in cancer therapeutic, diagnostic and theranostics. The versatile and unique physio-chemistry of MXenes permits fine tuning of its properties towards oncological applications ranging from the cancer therapeutic (e.g., photothermal therapy, photodynamic therapy, radiation therapy, chemotherapy) to cancer imaging (e.g., CT/MRI/PA imaging) as well as cancer theranostic applications. We have started the discussion by portraying the broad picture of physio-chemical aspects of MXenes followed by its drug delivery functionalities. Subsequently, ROS mediated therapeutic strategies of photodynamic therapy and radiotherapy as well as light triggered functionalities of MXenes were detailed comprehensively. In the middle of the gallery, various imaging and sensing aspects of MXenes were elucidated. Finally, we have concluded by explaining the combined therapy and diagnostic functions (theranostics) of MXenes. To put it in perspective, the current challenges and new opportunities in MXenes also discussed will give great realistic insights to motivate further research in realizing MXene as an intelligent oncological tool.

20 March 2025 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
AMAyeskanta Mohanty
Ayeskanta Mohanty
AMAdityanarayan Mohapatra
Adityanarayan Mohapatra
WYWoojin Yang
Woojin Yang
SCSeunghyun Choi
Seunghyun Choi
ASAravindkumar Sundaram
Aravindkumar Sundaram
IPIn-Kyu Park
In-Kyu Park

2 October 2023 in Nanoscale
Verified
Journal Article
Open access
PDF file
KEKarolinekersin Enoch
Karolinekersin Enoch
ASAravindkumar Sundaram
Aravindkumar Sundaram
SPStephen Selvamani Ponraj
Stephen Selvamani Ponraj
SPSathya Palaniyappan
Sathya Palaniyappan
SGSahaya Dennis Babu George
Sahaya Dennis Babu George
RMRajesh Kumar Manavalan
Rajesh Kumar Manavalan
The integration of metal oxides into MXene structures has been instrumental in boosting high surface area, electrical conductivity, stability, and sensitivity. This points to a promising future for biomedical applications.

26 September 2023 in Biomaterials Science
Verified
Journal Article
Open access
PDF file
VVVeena Vijayan
Veena Vijayan
ASAravindkumar Sundaram
Aravindkumar Sundaram
AVArathy Vasukutty
Arathy Vasukutty
RBRizia Bardhan
Rizia Bardhan
SUSaji uthaman
Saji uthaman
IPIn-Kyu Park
In-Kyu Park
Magnetic hyperthermia has attracted considerable attention for efficient cancer therapy because of its noninvasive nature, deep tissue penetration, and minimal damage to healthy tissues. Herein, we have fused cancer cell membrane fragments with lipids and cloaked them on magnetic nanorings to form targeted Fe nanorings (TF) for tumor-targeted magnetic hyperthermia-induced tumor ablation. In our approach, cell membrane fragments from cancer cells were fused with lipids to form vesicles, which could efficiently encapsulate magnetic nanorings, thereby forming TF. We observed that TF have high tumor uptake via homotypic targeting, where cancer cells take up TF through membrane fusion. Under an external alternating magnetic field (AMF), TF accumulated in the tumors are heated, driving magnetic-hyperthermia-induced tumor cell death. Our in vitro studies show that self-targeting TF efficiently localized in cancer cells and induced cell death with an AMF, which was shown by a live/dead assay. Our findings demonstrate the potential of TF in tumor ablation, thereby making them promising and efficient nanosystems for tumor-targeted theranostics.

19 July 2023 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
SKSubin Kim
Subin Kim
ASAravindkumar Sundaram
Aravindkumar Sundaram
AMAnsuja Pulickal Mathew
Ansuja Pulickal Mathew
VHVasvani Shyam Hareshkumar
Vasvani Shyam Hareshkumar
AMAdityanarayan Mohapatra
Adityanarayan Mohapatra
YJYong Yeon Jeong
Yong Yeon Jeong
Radiation therapy (RT) is a mainstream clinical approach in cancer treatment. However, the therapeutic efficacy of RT is greatly hindered by the presence of excessive hydrogen peroxide (H2O2) in the hypoxic region of the solid tumor, thus leading to tumor recurrence and metastasis. Herein, a thioketal-linked amphiphilic nano-assembly (MTS) loaded with hydrophobic manganese oxide (HMO) nanoparticles (MTS@HMO) is examined as a promising multi-purpose reactive oxygen species (ROS)-catalytic nanozyme for transforming an RT-resistant hypoxic tumor microenvironment (TME) into an RT-susceptible one by scavenging ROS in the hypoxic core of the solid tumor. After intravenous injection, the MTS@HMO nano-assembly was able to sense and be degraded by the abundant ROS in the hypoxic TME, thereby releasing HMO particles for subsequent scavenging of H2O2. The oxygen generated during peroxide scavenging then relieved the hypoxic TME, thereby resulting in an increased sensitivity of the hypoxic tumor tissue towards RT. Moreover, the in situ hypoxic status was monitored via the T1-enhanced magnetic resonance (MR) imaging of the Mn2+ ions generated by the ROS-mediated degradation of HMO. The in vitro results demonstrated a significant H2O2 elimination and enhanced oxygen generation after the treatment of the MTS@HMO nano-assembly with tumor cells under hypoxic conditions, compared to the control MTS group. In addition, the combination of RT and pre-treatment with MTS@HMO nano-assembly significantly amplified the permanent DNA strand breaks in tumor cells compared to the control RT group. More importantly, the in vivo results proved that the systemic injection of the MTS@HMO nano-assembly prior to RT irradiation enhanced the RT-mediated tumor suppression and down-regulated the hypoxic marker of HIF-1α in the solid tumor compared to the control RT group. Overall, the present work demonstrates the great potential of the versatile ROS-catalytic hypoxia modulating strategy using the MTS@HMO nano-assembly to enhance the RT-induced antitumor efficacy in hypoxic solid tumors.

22 May 2025 in Chemical Engineering Journal
Verified
Journal Article
Closed access
SPSathiyamoorthy Padmanaban
Sathiyamoorthy Padmanaban
SKSree Samanvitha Kuppa
Sree Samanvitha Kuppa
OSOmkar Sangabathula
Omkar Sangabathula
ABAmal Babu
Amal Babu
AMAdityanarayan Mohapatra
Adityanarayan Mohapatra
IPIn-Kyu Park
In-Kyu Park